XNYS
VEEV
Market cap46bUSD
Oct 08, Last price
284.84USD
1D
0.83%
1Q
49.82%
Jan 2017
599.85%
IPO
584.71%
Name
Veeva Systems Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Veeva Systems Inc. is a global provider of specialized cloud-based software solutions designed exclusively for the life sciences sector. Its reach extends across key regions including North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. Among its core offerings is the Veeva Commercial Cloud, a comprehensive platform integrating software, data, and analytics to optimize commercial operations. This suite comprises various modules such as Veeva CRM (including specialized Medical CRM), Veeva CLM, Veeva CRM MyInsights, Approved Email, Engage, Align, Events Management, Veeva Nitro, OpenData, Link, Network, Crossix, Data Cloud, and MyVeeva for Patients. Veeva also provides Veeva Vault, an enterprise-grade, cloud-based application suite for content and data management. Vault streamlines critical functions across both commercial and research & development domains. For commercial teams, this includes sales, marketing, and medical content and communications. On the R&D side, it addresses areas like clinical trials, regulatory affairs, quality assurance, and patient safety. Beyond its software products, Veeva offers a comprehensive array of professional and support services. These services span implementation planning, project management, requirements analysis, solution design, and system configuration. They also encompass managing system environments, facilitating business process transformation related to Veeva solutions, and providing technical consulting for data migration and system integrations. Additionally, the company delivers training on its platforms and offers ongoing managed services, including outsourced systems administration. Established in 2007, the company originally operated as Verticals onDemand, Inc. before rebranding as Veeva Systems Inc. in April 2009. Its corporate headquarters are located in Pleasanton, California.
Key people
Gordon Ritter
Independent Chairman of the Board · since 2008
Thomas Schwenger
President and Chief Customer Officer · since 2024
E. Nitsa Zuppas
President, Chief of Staff · since 2024
Brian Van Wagener
Chief Financial Officer · since 2024
Jonathan Faddis
Senior Vice President, General Counsel, Secretary · since 2016
Stacey Epstein
Chief Marketing Officer · since 2024
Peter Gassner
Chief Executive Officer, Director · since 2007
Independent Director · since 2024
Independent Director · since 2017
Independent Director · since 2019
Independent Director · since 2022
Independent Director · since 2022
Independent Director · since 2014
Matthew Wallach
Independent Director · since 2022
Legal address
C/O CORPORATION SERVICE COMPANY
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
Headquarters
4280 Hacienda Drive
Pleasanton, CA 94588
US
Pleasanton, CA 94588
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑01 | 2025‑01 | 2024‑01 | 2023‑01 | 2022‑01 | 2021‑01 | 2020‑01 | 2019‑01 | 2018‑01 | 2017‑01 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||